Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples